Asif Iqbal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Asif Iqbal has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
A. Balofsky
Department of Anesthesiology, University of Rochester Medical Center, Rochester, NY, USA
1 shared publicationA.V.H. Wellala
1 shared publicationAjay Pant
Professor and Head, Department of Orthopaedics, Teerthanker Mahaveer Medical College and Research Centre, Moradabad, U.P, India
1 shared publicationBaitule Sudhanshu G
1 shared publication- Bridget M. Marroquin
Department of Anesthesiology, University of Rochester Medical Center, Rochester, NY, USA
1 shared publication - Changyong Feng
Department of Biostatistics and Computational Biology, School of Medicine and Dentistry, University of Rochester, Rochester, USA
1 shared publication
Latest Publications
- 27 October 2022
- Published by Bioscientifica in Endocrine Abstracts
- Vol. 86
Medical optimisation and multidisciplinary approach to management of hyperparathyroid crisis in an elderly patient
Primary hyperparathyroidism causing symptomatic hypercalcaemia is often encountered in clinical practice. However, hyperparathyroid crisis is a rare and potentially fatal presentation of primary hyperparathyroidism characterised by profoundly symptomatic hypercalcaemia, altered mental status, and cardiac and renal dysfunction. Recognising the need for rapidly controlling hypercalcaemia with aggressive medical therapy and definitive management with early parathyroidectomy are necessary to reduce morbidity and mortality. A 89-year-old man presenting with six weeks history of lethargy, polyuria, polydipsia, confusion and acute kidney injury was found to have raised serum calcium of 3.5 mmo/l (2.10-2.58), suppressed serum phosphate and highest parathyroid hormone (PTH) level of 178.2 pmol/l (1.6-6.9). An ultrasound neck revealed 3.5 cm hypoechoic likely parathyroid neoplasm in the right inferior thyroid pole. He was aggressively treated with intravenous fluids, cinacalcet and intravenous bisphosphonates. Due to refractory symptomatic hypercalcaemia, suspected parathyroid carcinoma and need for withholding anticoagulant, calcitonin was used as a bridging therapy allowing safe and early parathyroidectomy on 14th day of admission. An enlarged superior parathyroid located posterior to recurrent laryngeal nerve and adherent to surrounding structures was removed successfully under local anaesthesia. It resulted in complete resolution of hypercalcaemia and associated symptoms and electrolyte abnormalities. His PTH reduced to 1.2 pmol/l on 3rd and calcium to 1.94 mmol/l on 5th day post-surgery, the later treated with oral calcium and alfacalcidiol. On histopathologic examination, the parathyroid specimen showed multiple fragments with an encapsulated zone of proliferation, compressed normal parathyroid tissue focally in the peripheral regions and no evidence of complete capsular transgression or vascular invasion. These features are suggestive of parathyroid adenoma; immunohistochemical examination is pending. Our case demonstrates challenges of managing hyperparathyroid crisis. Aggressive control of hypercalcaemia, with multiple therapeutic agents, and definitive management with early parathyroidectomy after optimising patient’s condition are crucial for a successful outcome.
- 27 October 2022
- Published by Bioscientifica in Endocrine Abstracts
- Vol. 86
Medical optimisation and multidisciplinary approach to management of hyperparathyroid crisis in an elderly patient
Primary hyperparathyroidism causing symptomatic hypercalcaemia is often encountered in clinical practice. However, hyperparathyroid crisis is a rare and potentially fatal presentation of primary hyperparathyroidism characterised by profoundly symptomatic hypercalcaemia, altered mental status, and cardiac and renal dysfunction. Recognising the need for rapidly controlling hypercalcaemia with aggressive medical therapy and definitive management with early parathyroidectomy are necessary to reduce morbidity and mortality. A 89-year-old man presenting with six weeks history of lethargy, polyuria, polydipsia, confusion and acute kidney injury was found to have raised serum calcium of 3.5 mmo/l (2.10-2.58), suppressed serum phosphate and highest parathyroid hormone (PTH) level of 178.2 pmol/l (1.6-6.9). An ultrasound neck revealed 3.5 cm hypoechoic likely parathyroid neoplasm in the right inferior thyroid pole. He was aggressively treated with intravenous fluids, cinacalcet and intravenous bisphosphonates. Due to refractory symptomatic hypercalcaemia, suspected parathyroid carcinoma and need for withholding anticoagulant, calcitonin was used as a bridging therapy allowing safe and early parathyroidectomy on 14th day of admission. An enlarged superior parathyroid located posterior to recurrent laryngeal nerve and adherent to surrounding structures was removed successfully under local anaesthesia. It resulted in complete resolution of hypercalcaemia and associated symptoms and electrolyte abnormalities. His PTH reduced to 1.2 pmol/l on 3rd and calcium to 1.94 mmol/l on 5th day post-surgery, the later treated with oral calcium and alfacalcidiol. On histopathologic examination, the parathyroid specimen showed multiple fragments with an encapsulated zone of proliferation, compressed normal parathyroid tissue focally in the peripheral regions and no evidence of complete capsular transgression or vascular invasion. These features are suggestive of parathyroid adenoma; immunohistochemical examination is pending. Our case demonstrates challenges of managing hyperparathyroid crisis. Aggressive control of hypercalcaemia, with multiple therapeutic agents, and definitive management with early parathyroidectomy after optimising patient’s condition are crucial for a successful outcome.
- 1 May 2017
- Published by Elsevier in International Journal of Obstetric Anesthesia
- Vol. 30, 16-22
Neuraxial opioids for post-cesarean delivery analgesia: can hydromorphone replace morphine? A retrospective study
- 1 May 2017
- Published by Elsevier in International Journal of Obstetric Anesthesia
- Vol. 30, 16-22
Neuraxial opioids for post-cesarean delivery analgesia: can hydromorphone replace morphine? A retrospective study
- Open Access
- 9 December 2014
- Published by Marwah Infotech in Acta Medica International
- Vol. 1 (1) , 10-14
Pattern of Orthopaedic injuries among patients attending the emergency department in a tertiary care hospital - An analytical study
- 9 December 2014
- Published by Marwah Infotech in Acta Medica International
- Vol. 1 (1) , 10-14
Open AccessPattern of Orthopaedic injuries among patients attending the emergency department in a tertiary care hospital - An analytical study